InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Theravance Biopharma, Inc.

TBPH Clue Score61
United States Fiscal year ends December CIK 0001583107 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Eli Samaha
7 Aug 2024
10% owner
Buy indirect
999,800
$7.80
$7.80M
Eli Samaha
1 May 2024
10% owner
Buy indirect
499,324
$8.75
$4.37M
Eli Samaha
1 May 2024
10% owner
Buy indirect
999,800
$8.75
$8.75M
Burton G Malkiel
21 May 2018
Director
Buy
1,000
$22.54
$22.54K
Frank Pasqualone
21 Aug 2017
SVP, Chief Comm Ops Officer
Buy
4,000
$26.34
$105.36K
Rick E Winningham
11 Aug 2017
Chief Executive Officer
Buy
10,000
$24.50
$245.00K
Henrietta Fore
11 Aug 2017
Director
Buy
6,000
$23.99
$143.93K
Burton G Malkiel
11 Aug 2017
Director
Buy indirect
15,000
$24.59
$368.82K
Burton G Malkiel
11 Aug 2017
Director
Buy
15,000
$24.59
$368.85K
George M Whitesides
11 Aug 2017
Director
Buy indirect
4,000
$24.69
$98.76K
Show all 85 transactions →

What was left out

Form 4 filings counted 515
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 1
Joint filings 1
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 5
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 30,222,989
Sales filed before the plan box existed 35
History held since 19 May 2014